Discover 776 paid clinical trials in Round Rock, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 776
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
for
Narcolepsy Type 2
Location: Austin TX, San Antonio TX, Sugar Land TX, Frisco TX,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07502443
Phase3, Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Austin TX, San Antonio TX, Sugar Land TX,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT06767683
Phase2, Phase3, Recruiting
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
for
Narcolepsy Type 2
Location: Austin TX, San Antonio TX, El Paso TX, St Louis MO,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06952699
Phase2, Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Austin TX, San Antonio TX, Fort Worth TX, Tyler TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Austin TX, Woodland TX, Fort Worth TX, Dallas TX,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT05579366
Phase1, Phase2, Recruiting
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
for
Lung Neoplasm Malignant
Location: Austin TX, Tyler TX, Daphne AL, Lone Tree CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06788912
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Austin TX, San Antonio TX, Fort Worth TX, Webster TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase3, Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
for
Stage III Ovarian Cancer, Stage IV Ovarian Cancer,
Location: Austin TX, Houston TX, New Orleans LA, Overland Park KS,
Sponsor: GOG Foundation
Sex: Female
Age: 18+
Code: NCT05659381
Phase3, Recruiting
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Austin TX, Hot Springs AR, Springfield MO,